Literature DB >> 2935445

Measurement of portal vascular resistance in patients with portal hypertension.

F Moriyasu, O Nishida, N Ban, T Nakamura, K Miura, M Sakai, T Miyake, H Uchino.   

Abstract

Portal vascular resistance was measured percutaneously in 60 patients with chronic liver disease and in 5 control subjects. The portal vascular resistance (PVR) was calculated, using the following equation, from the portal blood flow (QPV), portal venous pressure (PPV), and hepatic venous pressure (PHV): PVR = (PPV - PHV)/QPV. The portal blood flow was measured using an ultrasonic Doppler duplex system, and the portal venous and hepatic venous pressures were measured using percutaneous transhepatic catheterization and venous catheterization, respectively. The wedged hepatic venous pressure was measured by occluding the hepatic venous branch using a balloon catheter. The portal vascular resistance was 0.25 +/- 0.13 mmHg X ml-1 X min X kg body weight (mean +/- SD, n = 5) in the control group, 0.64 +/- 0.29 mmHg X ml-1 X min X kg body wt (n = 13) in the chronic active hepatitis group, 1.34 +/- 0.79 mmHg X ml-1 X min X kg body wt (n = 30) in the cirrhosis group, and 0.85 +/- 0.69 mmHg X ml-1 X min X kg body wt (n = 13) in the idiopathic portal hypertension group.

Entities:  

Mesh:

Year:  1986        PMID: 2935445     DOI: 10.1016/0016-5085(86)91127-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

Review 1.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

2.  Enhancement of the liver on dynamic MDCT: investigation among three groups consisting of noncirrhotic patients and cirrhotic patients with and without a large portosystemic shunt.

Authors:  Kouichirou Naruo; Mitsuhiro Tozaki; Yasushi Fukuda; Kunihiko Fukuda
Journal:  Radiat Med       Date:  2007-04-27

3.  Portal vein pulsatility index is a more important indicator than congestion index in the clinical evaluation of right heart function.

Authors:  Cheng-Yen Shih; Sien-Sing Yang; Jui-Ting Hu; Chin-Lin Lin; Yung-Chih Lai; Cheng-Wen Chang
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

4.  Splenectomy with endoscopic variceal ligation is superior to splenectomy with pericardial devascularization in treatment of portal hypertension.

Authors:  Nan Lin; Bo Liu; Rui-Yun Xu; He-Ping Fang; Mei-Hai Deng
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

5.  Effect of propranolol on portal vein hemodynamics: assessment by duplex sonography and indocyanine green clearance in healthy volunteers.

Authors:  W G Zoller; D R Wagner; J Zentner
Journal:  Clin Investig       Date:  1993-08

6.  Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization.

Authors:  Yu Zhang; Tian-Fu Wen; Lu-Nan Yan; Hong-Ji Yang; Xiao-Fan Deng; Chuan Li; Chuan Wang; Guan-Lin Liang
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

7.  A new method for diagnosis of cirrhosis disease: complex-valued artificial neural network.

Authors:  Yüksel Ozbay
Journal:  J Med Syst       Date:  2008-10       Impact factor: 4.460

8.  Percentage of peak-to-peak pulsatility of portal blood flow can predict right-sided congestive heart failure.

Authors:  Jui-Ting Hu; Sien-Sing Yang; Yun-Chih Lai; Cheng-Yen Shih; Cheng-Wen Chang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Difference in regional hepatic blood flow in liver segments--non-invasive measurement of regional hepatic arterial and portal blood flow in human by positron emission tomography with H2(15)O.

Authors:  H Taniguchi; A Oguro; K Takeuchi; K Miyata; T Takahashi; T Inaba; H Nakahashi
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

10.  Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection.

Authors:  A Deplano; V Migaleddu; A Pischedda; G Garrucciu; G Gregu; C Multinu; M Piredda; A Tocco; F Urigo; P A Cossu; A Solinas
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.